Genelux Corporation Common Stock (GNLX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.89
• Market Cap: $132.81M
• EPS: $-0.88
• 52-Week High: $8.54
• 52-Week Low: $1.99

Market Sentiment

Genelux Corporation Common Stock currently has a Bearish sentiment score of -0.33.

About Genelux Corporation Common Stock

Genelux Corporation (GNLX) is a clinical-stage biopharmaceutical company based in Westlake Village, California, focused on developing cutting-edge oncolytic viral immunotherapies for aggressive solid tumors. The company utilizes its proprietary technology platform to create innovative treatments that activate and enhance the immune response against cancer, aiming to improve overall patient outcomes in oncology. With a promising pipeline of therapies, Genelux is well-positioned to impact the i...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Genelux Corporation Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GNLX pay dividends?

Genelux Corporation Common Stock (GNLX) does not currently pay a regular dividend.

What is GNLX's market cap?

Genelux Corporation Common Stock (GNLX) has a market capitalization of $132.81M with a current stock price of $2.89.